Drugs with this side effect
- 4-PBA: common
- 5-ASA: very rare, postmarketing
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 24% - 89.2%
- 5-azacytidine: very common, 3.2% - 69.7%
- 5-fluorocytosine
- 6-mercaptopurine
- 6-thioguanine
- A77 1726
- APAs
- Anidulafungin
- BCNU: 1%
- BPTI
- Benicar-HCT
- Bivalirudin: postmarketing, 0.3% - 1.1%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas: uncommon
- Carfilzomib: 10.3% - 36.3%
- D-penicillamine: 4%
- EACA
- Enfuvirtide
- Eptifibatide: postmarketing, uncommon, 0.192% - 0.2%
- FAMP
- FK463: 3.96% - 77.1%
- FdUrd
- Ge-132: 2%
- Glat copolymer: postmarketing
- Goserelin
- K779: postmarketing, 1% - 7%
- L-Dmp: postmarketing, rare
- LMWH: postmarketing, 1.5% - 2.8%
- LY146032: 1%
- Lisinopril: very rare, postmarketing
- MDV3100
- Madopar
- Mersyndol
- NSC 352122
- NTBC: common
- Octreotide: postmarketing
- PCI-32765
- PGE1
- Romidepsin: 0% - 72.3%
- SU5416
- Saxagliptin
- Stalevo 50
- Supremon
- T-A2-3
- Timentin
- UDCA: postmarketing
- VACV: very rare, postmarketing, rare, 0.1% - 5%
- Vancocine: postmarketing
- Zyprexa Relprevv: very rare
- abacavir
- abacavir-lamivudine: uncommon
- acamprosate: infrequent
- acarbose: postmarketing
- acetaminophen: postmarketing
- acetazolamide
- actinomycin D
- acyclovir: very rare, postmarketing
- adefovir dipivoxil
- albendazole
- alfuzosin: postmarketing
- allopurinol
- alpha-methyl-p-tyrosine
- amiodarone: postmarketing, 1.57% - 1.72%
- amitriptyline
- amlodipine
- amlodipine besylate
- amoxapine: postmarketing
- amoxicillin: very rare, postmarketing
- amphotericin B: 5.8% - 12.8%
- ampicillin
- amsacrine
- anagrelide: 9%
- anthracycline
- apixaban: uncommon
- aprepitant
- aripiprazole: uncommon
- arsenic
- arsenic trioxide: common
- asenapine
- aspirin
- atenolol: postmarketing
- atorvastatin: postmarketing
- atovaquone: postmarketing
- auranofin: postmarketing, 0.9% - 2.2%
- axitinib
- azathioprine: common
- azithromycin: postmarketing
- aztreonam
- belinostat: 7% - 16%
- benazepril
- benazeprilat
- bendamustine: 23%
- bendrofluazide
- benzathine penicillin
- betaxolol
- bexarotene: 10%
- bezafibrate
- bicalutamide
- bisoprolol
- bleomycin hydrochloride
- boceprevir: postmarketing, common
- bortezomib: 1.2% - 55%
- bosentan: postmarketing, uncommon
- bosutinib: 25.4% - 41%
- bromcresol green
- bumetanide: 0.2%
- bupropion: postmarketing
- buspirone: rare
- busulfan
- cabazitaxel: 2% - 47.4%
- cabozantinib: 0% - 35%
- candesartan: postmarketing
- candesartan cilexetil
- capecitabine: 1% - 24%
- capreomycin
- captopril
- carbamazepine: very rare, common
- carbenicillin
- carbidopa
- carbimazole
- carbinoxamine
- carboplatin: 62%
- carvedilol: 0.1% - 2%
- cefaclor: postmarketing
- cefadroxil
- cefazolin
- cefdinir: postmarketing
- cefditoren: postmarketing
- cefepime: postmarketing
- cefixime: postmarketing
- cefotaxime: postmarketing
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftaroline
- ceftazidime: uncommon
- ceftizoxime
- ceftriaxone: postmarketing
- cefuroxime: postmarketing
- cefuroxime axetil
- celecoxib
- cephalexin
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorambucil
- chloramphenicol
- chloroquine
- chlorpheniramine
- chlorpropamide
- chlorthalidone: rare
- choline theophyllinate
- cidofovir
- cilazapril: postmarketing
- cilostazol: postmarketing
- cimetidine: rare
- cinoxacin
- ciprofloxacin: postmarketing, rare, uncommon
- cisplatin
- citalopram: postmarketing
- cladribine: very common, 6% - 12%
- clarithromycin: postmarketing
- clemastine
- clindamycin
- clindamycin phosphate
- clobazam: postmarketing
- clofarabine: 79.8% - 80.7%
- clomipramine: very rare
- clonazepam
- clonidine
- clozapine: postmarketing
- colchicine: postmarketing
- copolymer 1: postmarketing
- cyclobenzaprine: postmarketing
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone acetate
- cytarabine: 5% - 32.1%
- d-telaprevir
- dabigatran: postmarketing
- dabigatran etexilate: uncommon
- dabrafenib: 0% - 31%
- dacarbazine
- dalbavancin
- dalteparin
- danazol
- dantrolene
- darunavir
- dasatinib: postmarketing, 5% - 85%
- deferasirox: postmarketing
- deferoxamine: very rare
- delamanid
- delavirdine: 1.4%
- demeclocycline
- deprenyl
- desipramine
- dexamethasone
- dexmedetomidine
- dexrazoxane
- diatrizoate
- diazepam
- diazoxide
- dichlorphenamide
- diclofenac: very rare
- dicloxacillin
- didanosine: postmarketing
- diflunisal
- digoxin
- diltiazem: postmarketing
- diphenhydramine
- dipyridamole
- disopyramide
- dobutamine
- docetaxel: rare, 0% - 47%
- dolasetron
- donepezil: infrequent
- doripenem: postmarketing, uncommon
- dothiepin
- doxazosin: postmarketing
- doxepin
- doxorubicin: uncommon, common, very common, 0% - 51.4%
- doxycycline: postmarketing
- doxycycline calcium
- doxycycline hyclate
- duloxetine: postmarketing, infrequent
- efavirenz
- emtricitabine: postmarketing
- entacapone
- eprosartan
- eribulin
- erlotinib
- ertapenem
- eslicarbazepine acetate
- esomeprazole magnesium
- estramustine: 1% - 2%
- estramustine phosphate: 1% - 2%
- ethacrynic acid
- ethambutol
- ethionamide
- etodolac
- etoposide: 23%
- etoposide phosphate
- etoricoxib: postmarketing
- etravirine
- everolimus: common, very common, 0% - 19%
- exemestane
- ezetimibe: postmarketing
- famciclovir: very rare, postmarketing, rare
- famotidine
- febuxostat
- felbamate: infrequent
- fenofibrate
- fenoprofen
- fentanyl
- flecainide
- flucloxacillin: very rare
- fluconazole: postmarketing
- fludarabine
- fluoxetine: postmarketing, rare
- flurbiprofen
- flutamide
- fluticasone: postmarketing
- fluvastatin: very rare, postmarketing
- fluvoxamine: rare, infrequent
- fondaparinux: postmarketing, uncommon
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin: infrequent
- fotemustine
- furosemide: uncommon
- fusidic acid
- gabapentin: postmarketing, infrequent
- gadolinium
- gadoversetamide
- galantamine: rare, infrequent
- ganciclovir: 5% - 6.6%
- gatifloxacin: postmarketing
- gefitinib
- gemcitabine: postmarketing, very common, 1% - 57%
- gemfibrozil
- gemifloxacin
- gentamicin
- glibenclamide
- gliclazide
- glimepiride: postmarketing
- glipizide: postmarketing
- gold sodium thiomalate: 1 - 3%
- granisetron: 2%
- guanidinium
- haloperidol: very rare, postmarketing
- hemin: postmarketing
- heparin
- hepatitis B vaccines
- hexamethylmelamine
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydrocodone
- hydroflumethiazide
- hydroxychloroquine
- hydroxyurea: common, 1-5%
- ibuprofen
- icodextrin: postmarketing
- idarubicin
- ifosfamide: 10%
- iloprost: postmarketing
- imatinib: postmarketing, very common, 0% - 97.8%
- imipramine: very rare
- indapamide
- indinavir
- indomethacin
- iodide
- irbesartan: postmarketing
- irbesartan-hydrochlorothiazide
- irinotecan: 0% - 98.6%
- isomannide
- isoniazid
- isosorbide-5-mononitrate
- isradipine
- itraconazole: postmarketing
- ixabepilone: 2% - 5%
- ketoconazole: postmarketing
- ketoprofen
- ketorolac: postmarketing
- ketorolac tromethamine: postmarketing
- ketotifen
- lamivudine: very rare, postmarketing, uncommon, 1% - 3%
- lamotrigine: rare
- lansoprazole: postmarketing
- lasofoxifene: uncommon
- leflunomide: postmarketing, uncommon
- lenalidomide: postmarketing, very common, 12.2% - 74%
- lercanidipine
- leucovorin: 1% - 18%
- leuprorelin acetate
- levetiracetam: postmarketing, common
- levodopa/carbidopa
- linezolid: postmarketing, 0% - 4.7%
- lomefloxacin
- lomustine
- lorazepam: postmarketing
- losartan: postmarketing
- lovastatin: postmarketing
- loxapine
- lymecycline
- maprotiline
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- melatonin
- meloxicam
- melphalan: very common
- memantine: postmarketing
- mephenytoin
- meropenem
- mesna
- metformin
- methadone
- methimazole
- methotrexate
- methyclothiazide
- methyldopa
- methylphenidate: very rare, postmarketing
- methysergide
- metolazone
- metoprolol: very rare, postmarketing
- metronidazole
- mexiletine
- mianserin
- miglustat: 5% - 7%
- milnacipran: postmarketing
- milrinone
- minocycline: postmarketing
- minoxidil
- mirtazapine: postmarketing, rare
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone: 33-39%
- montelukast: postmarketing
- morphine
- moxifloxacin
- mycophenolate mofetil: 3.5% - 42.2%
- mycophenolic acid: 23.5% - 42.2%
- nabumetone: 0.2%
- nalidixic acid
- naproxen: postmarketing
- naratriptan: rare
- nebivolol: postmarketing
- nefazodone: postmarketing
- nelarabine: 22% - 88%
- nelfinavir
- nevirapine
- nicardipine
- nicorandil
- nifedipine
- nilotinib: very common, 9% - 42%
- nimodipine
- nitric oxide
- nitrofurantoin
- nitrogen mustard
- nitrous oxide
- nizatidine
- norfloxacin: postmarketing
- nortriptyline
- ofatumumab
- ofloxacin: postmarketing
- olanzapine: very rare, postmarketing, infrequent
- olmesartan
- olsalazine
- omeprazole: postmarketing, rare
- oseltamivir: postmarketing
- oxaliplatin: postmarketing, rare, very common, 0% - 77.4%
- oxaprozin
- oxcarbazepine: very rare
- oxprenolol
- oxytetracycline
- paclitaxel: very common, 2% - 70%
- paliperidone: very rare, postmarketing
- pamidronate: common, 0% - 16.6%
- pantoprazole: very rare, postmarketing
- parecoxib
- paroxetine: very rare, postmarketing, rare
- pazopanib: 1% - 36%
- pemetrexed: 0% - 27%
- penciclovir: postmarketing
- penicillin
- penicillin V
- pentamidine
- pentosan polysulfate
- pentostatin: 6% - 32%
- pentoxifylline
- pergolide: infrequent
- perindopril: very rare
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- phenylbutyric acid: 3%
- phenytoin: infrequent
- pilocarpine
- piperacillin
- piroxicam
- pixantrone
- polythiazide
- pomalidomide: 1.7% - 27%
- ponatinib: 4% - 47%
- posaconazole
- pralatrexate
- pramipexole
- prasugrel: postmarketing
- pravastatin: postmarketing
- pregabalin: infrequent
- procainamide
- procaine penicillin
- procarbazine
- prochlorperazine
- promethazine
- propafenone: postmarketing
- propylthiouracil
- prostacyclin
- protriptyline
- pyrazinamide
- pyrimethamine
- quetiapine: rare
- quinapril
- quinaprilat
- quinidine
- rabeprazole: postmarketing
- radium: 2% - 31%
- raloxifene: uncommon
- raltegravir: postmarketing
- raltitrexed: 4%
- ramipril
- ramiprilat
- ranitidine
- ranolazine
- rapamycin: 7% - 30%
- rasburicase
- regorafenib: 41%
- remifentanil: 0% - 2.44%
- repaglinide
- retigabine
- retinoic acid: postmarketing
- ribavirin: common, 1% - 8%
- rifabutin: 5%
- rifampicin
- rifapentine
- riluzole
- risperidone: postmarketing, rare
- ritonavir: 5%
- rivastigmine: infrequent, frequent
- rofecoxib
- ropinirole: infrequent, frequent
- ropivacaine: 2%
- rosiglitazone: common
- rosuvastatin: postmarketing
- rufinamide: infrequent
- ruxolitinib: very common, 3.9% - 69.8%
- samarium: 69.3%
- saquinavir
- sertraline: postmarketing, rare
- sevoflurane
- sibutramine
- silver sulfadiazine
- simvastatin: postmarketing
- sitaxsentan
- sorafenib: postmarketing, common
- sotalol: postmarketing
- sparfloxacin: postmarketing
- spironolactone
- stavudine: very rare, postmarketing
- stiripentol
- streptomycin
- streptozotocin: 1%
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 1%
- sulindac
- sumatriptan: postmarketing
- sunitinib: postmarketing, 1%
- tacrolimus: common, 14% - 24%
- tamoxifen: 2%
- telavancin: uncommon
- telmisartan: postmarketing, rare
- temazepam
- temozolomide: common, very common, 0% - 9%
- temsirolimus
- teniposide: 85%
- tenofovir disoproxil fumarate: postmarketing
- tenoxicam
- terazosin: postmarketing
- terbinafine: very rare, postmarketing
- testosterone: postmarketing
- tetracycline
- thalidomide: 0% - 11.3%
- thiazide
- thioridazine: postmarketing
- thiotepa
- thiothixene
- thymidine: 0% - 1%
- tiagabine: infrequent
- tiaprofenic acid
- ticlopidine
- tigecycline: postmarketing, uncommon
- tinidazole
- tiopronin
- tipranavir: uncommon
- tirofiban: postmarketing
- tizanidine: rare
- tobramycin
- tolazamide
- tolbutamide
- tolcapone: rare
- tolmetin
- topiramate: postmarketing, 1%
- topotecan: postmarketing, common, very common, 0.5% - 81%
- torasemide: postmarketing
- toremifene
- trabectedin
- tramadol: postmarketing, uncommon
- trametinib: 0% - 31%
- trandolapril
- trandolaprilat: postmarketing
- tranylcypromine
- treprostinil: postmarketing
- triamterene
- trimethadione
- trimethoprim: very rare
- trimethoprim-sulfamethoxazole: very rare
- trimetrexate: 0% - 33.3%
- trimipramine
- trovafloxacin
- v 1784: postmarketing, uncommon
- valdecoxib
- valganciclovir: 3% - 5%
- valproate: 1% - 24%
- valsartan: postmarketing
- vandetanib
- varenicline: rare
- venlafaxine: rare, infrequent
- vinblastine
- vincristine: 16.9%
- vinflunine
- vinorelbine: 0% - 21%
- voriconazole: common, 0% - 1.08%
- vorinostat
- x M22
- zafirlukast
- zalcitabine
- zidovudine: uncommon, 0% - 3%
- zidovudine/lamivudine
- ziprasidone: rare
- zoledronic acid: uncommon
- zolmitriptan: rare
- zonisamide: rare
- zuclopenthixol
|
Drugs with this indication
|